Macroagregados De Albúmina Humana

Technetium-99m macroaggregated human albumin, the active ingredient in Macroagregados De Albúmina Humana, is a radiopharmaceutical presented as a kit for preparation of a radiopharmaceutical solution for intravenous use. It is employed in nuclear medicine to assess pulmonary blood flow by labeling albumin particles that temporarily lodge in the lung capillaries, enabling lung perfusion imaging in adult and pediatric patients undergoing ventilation‑perfusion (V/Q) scans.

GNH USA supplies Macroagregados De Albúmina Humana as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Technetium‑99m macroaggregated human albumin is used in nuclear medicine to evaluate pulmonary perfusion and related diagnostic pathways. - Lung perfusion imaging: provides visualization of regional pulmonary blood flow for diagnostic assessment. - Ventilation‑perfusion (V/Q) scan: assists in detecting pulmonary embolism by comparing ventilation and perfusion patterns. - Pre‑operative assessment: helps evaluate lung function before thoracic or cardiac surgery.

Common Side Effects: - Mild headache: transient discomfort after injection. - Nausea: occasional feeling of queasiness. - Injection site pain: brief soreness at the venipuncture site. - Transient flushing: brief skin redness.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Pulmonary hypertension: sudden increase in pulmonary arterial pressure. - Embolic phenomena: rare lodging of particles causing vascular obstruction. - Radiation‑induced skin injury: localized skin changes at high exposure levels.

Precautions should be observed to ensure safe use of this radiopharmaceutical. - Patient selection: confirm indication and assess for contraindications. - Pregnancy: avoid unless the diagnostic benefit outweighs potential fetal risk. - Breastfeeding: consider temporary cessation or alternative imaging. - Renal function: evaluate because excretion may be altered. - Radiation safety: follow ALARA principles and protect staff. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Interactions with other agents may affect imaging quality or safety. Major Interactions (Avoid): - Concurrent radiopharmaceuticals emitting similar gamma energies: may cause image overlap. - High‑dose iodine contrast agents: can interfere with technetium detection. - Certain chemotherapeutic agents affecting bone marrow: increase radiation sensitivity. Moderate Interactions (Monitor Closely): - Beta‑blockers: may alter heart rate influencing perfusion patterns. - Diuretics: can modify pulmonary blood flow distribution. - ACE inhibitors: may affect capillary dynamics during imaging.